Regulation of human transmembrane serine protease
US6734006B2 · kind B2 · utility
15Cited by
0References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2001 |
| Grant date | May 11, 2004 |
| Priority date | — |
| Expiry date | Jun 13, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Reagents that regulate human transmembrane serine protease activity and reagents that bind to human transmembrane serine protease gene products can be used to regulate extracellular matrix degradation. Such regulation is particularly useful for treating COPD, metastasis of malignant cells, tumor angiogenesis, inflammation, atherosclerosis, neurodegenerative diseases, and pathogenic infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.